Search Result "Gilteritinib"
FLT3 Inhibition in Acute Myeloid Leukaemia â Current Knowledge and Future Prospects
Journal: Current Cancer Drug Targets
Volume: 20 Issue: 7 Year: 2020 Page: 513-531
Author(s): Francesca L. Hogan,Victoria Williams,Steven Knapper
Research Progress of Axl Inhibitors
Journal: Current Topics in Medicinal Chemistry
Volume: 19 Issue: 15 Year: 2019 Page: 1338-1349
Author(s): Zhi-Gang Sun,Jian-Hua Liu,Jin-Mai Zhang,Yong Qian
An Expedition on Synthetic Methodology of FDA-approved Anticancer Drugs(2018-2021)
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 24 Issue: 8 Year: 2024 Page: 590-626
Author(s):
The Evolving AML Genomic Landscape: Therapeutic Implications
Journal: Current Cancer Drug Targets
Volume: 20 Issue: 7 Year: 2020 Page: 532-544
Author(s): Sachi Horibata,George Alyateem,Christin B. DeStefano,Michael M. Gottesman
Protein Kinase Inhibitors as Therapeutic Drugs in AML: Advances and Challenges
Journal: Current Pharmaceutical Design
Volume: 23 Issue: 29 Year: 2017 Page: 4303-4310
Author(s): Yuan Ling,Zikang Zhang,Hua Zhang,Zunnan Huang
Drug-Induced QTc Prolongation: What We Know and Where We Are Going
Journal: Current Drug Safety
Volume: 17 Issue: 2 Year: 2022 Page: 100-113
Author(s): Jayne Pawasauskas,Todd N. Brothers,Elisa Sandonato,Erinn Mangona
Second-Generation Protein Kinase Inhibitor â A Focus on Quizartinib, A Promising Targeted Therapy for High-Risk FLT3+ Patients with Acute Myeloid Leukemia
Ebook: Frontiers in Clinical Drug Research - Anti-Cancer Agents
Volume: 5 Year: 2019
Author(s): Xavier Thomas,Etienne Paubelle
Doi: 10.2174/9789811405150119050003
Safe and Effective Kinase Inhibitors for the Treatment of Gynecological Cancers: In Silico Approach
Journal: Current Drug Metabolism
Volume: 22 Issue: 7 Year: 2021 Page: 537-549
Author(s): Vaishali M. Patil,Abhishek Kumar,Vaishali Anand,Priya Bansal,Neeraj Masand
Recent Progress of Oridonin and Its Derivatives for the Treatment of Acute Myelogenous Leukemia
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 20 Issue: 6 Year: 2020 Page: 483-497
Author(s): Xu Hu,Yan Wang,Xiang Gao,Shengtao Xu,Linghe Zang,Yan Xiao,Zhanlin Li,Huiming Hua,Jinyi Xu,Dahong Li
Developments of Fms-like Tyrosine Kinase 3 Inhibitors as AnticancerAgents for AML Treatment
Journal: Current Medicinal Chemistry
Volume: 31 Issue: 29 Year: 2024 Page: 4657-4686
Author(s):